Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Sternberg CN, Shin N, Chernyshov K, Calabro F, Cerbone L, Procopio G, et al. Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment. Front Oncol. 2022;12:1006017.

Magro CM, Mo JH, Pecker MS. Idiopathic systemic capillary leak syndrome, a unique complement and interferon mediated endotheliopathy syndrome: The role of the normal skin biopsy in establishing the diagnosis and elucidating pathogenetic mechanisms. Ann Diagn Pathol. 2022;61:152028.

Klein H, Mazor T, Siegel E, Trukhanov P, Ovalle A, Fitz CD, et al. MatchMiner: an open-source platform for cancer precision medicine. NPJ Precis Oncol. 2022;6(1):69.

Marino J, Maubert ME, Lawrence JM, Wigdahl B, Nonnemacher MR. Chronic Low Dose Morphine Does Not Alter Two In Vitro BBB Models. Brain Sci. 2022;12(7).

Kim J-, Yang Y-, Xie J, Lee O, Kim JH, Hong J, et al. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes. Cell Death Differ. 2022;29(8):1625-1638.

Makhani SS, Schwartz J, Vasovic LV, DeSimone RA, Kaicker S, Bussel J, et al. Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample. J Clin Apher. 2022;37(5):507-511.

Rivera-Cruz G, Boyraz B, Petrozza JC. How a woman's myomectomy saved her father's life: evidence of fumarate hydratase-deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase. F S Rep. 2022;3(1):26-31.

Stenzl A, Sternberg CN, Ghith J, Serfass L, Schijvenaars BJ, Sboner A. Application of artificial intelligence to overcome clinical information overload in urological cancer. BJU Int. 2022;130(3):291-300.

Jang J-, Hwang I, Pan H, Yao J, Alinari L, Imada E, et al. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas. J Clin Invest. 2022;132(24).

Cornell C, Khani F, Osunkoya AO, Matoso A, Miyamoto H, Gordetsky JB, et al. Secondary malignancy after urologic reconstruction procedures: a multi-institutional case series. Hum Pathol. 2022;119:69-78.